Latest Strategic Expansion News

Ragnar Metals advances its Swedish IOCG exploration with promising high-grade copper and gold assays, while strategically boosting its gold exposure through key investments in Kaiser Reef and High-Tech Metals.

Resonance Health reports positive cash flow and significant progress in its clinical trials and Software-as-a-Medical Device business, setting the stage for growth in new international markets.

Breakthrough Minerals Limited has voluntarily suspended trading on the ASX as it prepares to announce a significant mineral project acquisition and capital raising. The suspension is set to last until the announcement or the resumption of trading on 30 October 2025.

Nick Scali Limited reported a robust $62 million underlying profit for FY25, completed its UK acquisition equity raise, and announced key leadership changes as it eyes accelerated growth in FY26.

BlinkLab has completed its U.S. autism pilot study with strong diagnostic accuracy and expanded its pivotal FDA trial to seven leading research centers, positioning itself for regulatory submission in late 2026.

Lithium Plus Minerals is offering its shareholders a $3 million priority opportunity to invest in Moonlight Resources’ IPO, following Moonlight’s acquisition of the Clermont Gold Project. This move broadens Lithium Plus’s exposure beyond lithium into gold and rare earths through its 33.5% stake in Moonlight.

Skylark Minerals has completed initial fieldwork at its Simon Copper Project in Mt Isa and launched a new rare-earths desktop study in Brazil, while actively pursuing new gold assets and re-engaging on its Greenland zinc project.

Cash Converters has successfully completed the institutional component of a $25 million equity raising, positioning itself to acquire 29 franchise stores and expand its retail footprint.

Austco Healthcare kicks off FY26 with a robust 51% revenue increase and improved profitability, driven by strong organic growth and strategic acquisitions.

Power Minerals Limited has advanced its critical minerals portfolio with the acquisition of the Gamma Heavy Rare Earths and Uranium Project in California and completed the Santa Anna Niobium-REE-Gallium Project acquisition in Brazil, supported by a combined $6.7 million capital raise.

Tyranna Resources has advanced its exploration and acquisition efforts in Angola, securing a major stake in the Chinguar Gold Project and extending its lithium-caesium project tenure, supported by a solid cash position.

LTR Pharma has made significant strides towards its US market debut with ROXUS, bolstered by expert appointments and peer-reviewed clinical data validating its rapid-onset ED treatments.